In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
August 1st, 2006 | 24 | Yes |
Popular Name: 4-[5-(4-fluorophenyl)-2-(3-piperidyl)-1H-imidazol-4-yl]pyridine 4-[5-(4-fluorophenyl)-2-(3-piper…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.06 | -2.12 | -53.47 | 3 | 4 | 1 | 58 | 323.395 | 3 | ↓ |
Mid Mid (pH 6-8) | 2.06 | -1.98 | -114.46 | 4 | 4 | 2 | 59 | 324.403 | 3 | ↓ |
Lo Low (pH 4.5-6) | 2.06 | -2.01 | -89.89 | 4 | 4 | 2 | 59 | 324.403 | 3 | ↓ |
Lo Low (pH 4.5-6) | 2.06 | -1.87 | -180.63 | 5 | 4 | 3 | 60 | 325.411 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 140 | 0.40 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 19 | 0.45 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 19 | 0.45 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 19 | 0.45 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 19 | 0.45 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.41 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 585 | 0.36 | Functional ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 585 | 0.36 | Functional ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 585 | 0.36 | Functional ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 585 | 0.36 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 140 | 0.40 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 19 | 0.45 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 19 | 0.45 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 19 | 0.45 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 19 | 0.45 | Binding ≤ 1μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 110 | 0.41 | Binding ≤ 1μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 140 | 0.40 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 19 | 0.45 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 19 | 0.45 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 19 | 0.45 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 19 | 0.45 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 110 | 0.41 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 585 | 0.36 | Functional ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 585 | 0.36 | Functional ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 585 | 0.36 | Functional ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 585 | 0.36 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
CREB phosphorylation through the activation of Ras | |
DSCAM interactions | |
ERK/MAPK targets | |
FCERI mediated MAPK activation | |
GP1b-IX-V activation signalling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
KSRP destabilizes mRNA | |
MEK activation | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet sensitization by LDL | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Stimuli-sensing channels | |
VEGFA-VEGFR2 Pathway |